Vimpat and Rash erythematous - a phase IV clinical study of FDA data

Summary:

Rash erythematous is reported as a side effect among people who take Vimpat (lacosamide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Keppra, and have Depression.

The phase IV clinical study analyzes which people have Rash erythematous when taking Vimpat. It is created by eHealthMe based on reports of 20,279 people who have side effects when taking Vimpat from the FDA, and is updated regularly.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

What is Rash erythematous?

Rash erythematous (redness of the skin) is found to be associated with 1,810 drugs and 1,902 conditions by eHealthMe. Check the latest studies of Rash erythematous.

On Jul, 09, 2026

20,279 people reported to have side effects when taking Vimpat.
Among them, 30 people (0.15%) have Rash erythematous.

Among these 30 people:

How long have people been on Vimpat when they have Rash erythematous? *

What is the gender of people who have Rash erythematous when taking Vimpat? *

female: 53.57 %
male: 46.43 %

What is the age of people who have Rash erythematous when taking Vimpat? *

What are other drugs people take besides Vimpat? *

What are other side effects people have besides Rash erythematous? *

Itching: 12 people, 40.00%
Rashes (redness): 6 people, 20.00%
Fatigue (feeling of tiredness): 5 people, 16.67%
Drowsiness: 4 people, 13.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 13.33%
Rash Pruritic (redness with itching): 4 people, 13.33%
Dizziness: 4 people, 13.33%
Weakness: 4 people, 13.33%
Balance Disorder: 4 people, 13.33%
Depression: 4 people, 13.33%

What are the existing conditions these people have? *

Depression: 5 people, 16.67%
Stress And Anxiety: 3 people, 10.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 10.00%
Type 2 Diabetes: 2 people, 6.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 6.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 6.67%
Crying: 2 people, 6.67%
Delusional Disorder, Unspecified Type: 2 people, 6.67%
Dementia With Lewy Bodies (progressive degenerative disease or syndrome of the brain): 2 people, 6.67%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Vimpat and have Rash erythematous?

- Check whether Rash erythematous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vimpat:

Vimpat (20,831 reports)

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash erythematous:

Rash erythematous (1,810 drugs)

Browse all the conditions that are associated with Rash erythematous:

Rash erythematous (1,902 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide (the active ingredients of Vimpat) and Vimpat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.